Edition:
United States

People: IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

167.56USD
26 May 2017
Change (% chg)

$0.16 (+0.10%)
Prev Close
$167.40
Open
$166.97
Day's High
$167.98
Day's Low
$166.71
Volume
125,717
Avg. Vol
264,168
52-wk High
$171.98
52-wk Low
$85.98

Junius, Daniel 

Mr. Daniel M. Junius is Independent Director of Company. Mr. Junius has been a director of ImmunoGen, Inc. since July 2008 and GlycoMimetics, Inc. since March 2016. He was previously President and Chief Executive Officer of ImmunoGen from 2009 until his retirement in May 2016, President and Chief Operating Officer and Acting Chief Financial Officer from July 2008 to December 2008, Executive Vice President and Chief Financial Officer from 2006 to July 2008, and Senior Vice President and Chief Financial Officer from 2005 to 2006. Before joining ImmunoGen, Mr. Junius was Executive Vice President and Chief Financial Officer of New England Business Service, Inc. from 2002 until its acquisition by Deluxe Corporation in 2004, and Senior Vice President and Chief Financial Officer of New England Business Services from 1998 to 2002. Before joining New England Business Services, Mr. Junius was Vice President and Chief Financial Officer of Nashua Corporation from 1996 to 1998. Mr. Junius joined Nashua Corporation in 1984 and held various financial management positions of increasing responsibility before becoming Chief Financial Officer of Nashua Corporation in 1996. Mr. Junius was previously a director of Vitae Pharmaceuticals, Inc. from July 2016 until its acquisition by Allergan plc in October 2016. Mr. Junius holds an undergraduate degree in Political Science from Boston College and a Masters in Management from Northwestern University’s Kellogg School of Management. We value Mr. Junius’s depth of executive leadership, strategic thinking and financial expertise, as well as his extensive experience in the biotechnology field.

Basic Compensation

Total Annual Compensation, USD 80,000
Restricted Stock Awards, USD 43,775
Long-Term Incentive Plans, USD --
All Other, USD 131,767
Fiscal Year Total, USD 255,542

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jonathan Ayers

5,863,680

Brian McKeon

2,271,270

Giovani Twigge

1,275,260

Jay Mazelsky

2,070,160

Jacqueline Studer

1,283,200

William End

265,542
As Of  30 Dec 2016